Congenital hypothyroidism {#sec1-1}
=========================

Congenital hypothyroidism (CH) is the most common congenital endocrine disorder. It has a prevalence of 1:2000-4000 and is more frequent in females than in males (ratio of 2:1) ([@ref1]). At birth, clinical features are mild or absent, becoming apparent a few months later. The disorder is characterized by reduced physical activity, increased sleeping periods, feeding difficulties, constipation, jaundice, myxedematous face, wide fontanels, macroglossia, abdominal distention with umbilical hernia, and hypotonia. Developmental and growth delay become evident 4-6 months after birth Without therapy, the disorder leads to intellectual disability and very short stature ([@ref1]).

Congenital hypothyroidism can be caused by thyroid dysgenesis (85% of cases) or defects in thyroid hormone biosynthesis (10-15% of cases) ([@ref2]). Secondary congenital hypothyroidism is caused by chronic low levels of thyroid stimulating hormone (TSH) and may be due to congenital hypopituitarism. Peripheral congenital hypothyroidism is caused by defects in the transport, metabolism and action of thyroid hormones, or peripheral resistance to thyroid hormones ([@ref3]). Congenital hypothyroidism can also be syndromic.

Currently, neonatal screening mainly detects elevated levels of TSH that increase in response to the reduction in thyroid hormone. This screening identifies 90% of cases of CH. Most patients have normal development after treatment with thyroxine. Besides assay of TSH, triiodothyronine (T3) and thyroxine (T4), other diagnostic tests include thyroid scanning with radioactive iodine, thyroid echography, and assay of serum thyroglobulin. These exams can help determine the etiology of the disease and differentiate permanent and transient cases ([@ref1],[@ref4]). Differential diagnosis should consider chronic fatigue syndrome, depression, dementia and heart failure ([@ref5]).

Newborns diagnosed with CH should be treated with levothyroxine to ensure normal neurocognitive development. Serum levels of TSH, T4 and T3 should be measured frequently. When babies are treated soon after birth, their prognosis is excellent and their IQ normal ([@ref1]). Congenital hypothyroidism is usually sporadic, but in 10% of cases it is inherited ([@ref6]).

Generalized thyroid hormone resistance is a rare genetic disorder caused by a reduced peripheral response to thyroid hormones. The prevalence is 1:40000. In 85% of cases it is caused by mutations in *THRB* ([@ref7]).

Twenty-five genes are currently known to be associated with congenital hypothyroidism or generalized thyroid hormone resistance ([Table 1](#T1){ref-type="table"}). Pathogenic variants may be missense, nonsense, splicing or small indels. We use a multi-gene NGS panel to detect nucleotide variations in coding exons and flanking introns of the above genes.

###### 

Genes associated with congenital hypothyroidism

  Gene         OMIM gene   Disease                                                              OMIM disease           Inheritance   Gene function
  ------------ ----------- -------------------------------------------------------------------- ---------------------- ------------- --------------------------------------------------------------------------------------------------------------------------------------------
  *THRA*       190120      CHNG6                                                                614450                 AD            Nuclear hormone receptor mediator of T3 biological activity
  *NKX2-1*     600635      CAHTP                                                                610978                 AD            Transcription factor for expression of thyroid- specific genes
  *NKX2-5*     600584      CHNG5                                                                225250                 AD            Transcription factor for thyroid organogenesis
  *PAX8*       67415       CHNG2                                                                218700                 AD            Transcription factor for expression of thyroid- specific genes, maintenance of thyroid cell differentiation
  *POU1F1*     173110      CPHD1                                                                613038                 AD, AR        Transcription factor involved in specification of lactotrope, somatotrope and thyrotrope phenotypes in developing anterior pituitary gland
  *GNAS*       139320      PHP1A PHP1C                                                          103580 612462          AD            Activation of adenylate cyclase that regulates thyroid activity
  *SECISBP2*   607693      Abnormal thyroid hormone metabolism                                  609698                 AR            Co-translational insertion of selenocysteine into selenoproteins like type II iodothyronine deiodinase
  *THRB*       190160      GRTH PRTH                                                            188570 274300 145650   AD AR AD      Nuclear hormone receptor for triiodothyronine. Mediation of thyroid hormone activity
  *TRHR*       188545      Generalized thyrotropin-releasing hormone resistance                 188545                 AR            TRH receptor promoting TSH and prolactin release
  *KAT6B*      605880      GTPTS SBBYSS                                                         606170 603736          AD            Histone acetyltransferase transcriptional activator and repressor, also important for thyroid organogenesis
  *LHX4*       602146      CPHD4                                                                262700                 AD            Early stages of pituitary development
  *TSHB*       188540      CHNG4                                                                275100                 AR            Control of thyroid structure and metabolism
  *TSHR*       603372      CHNG1                                                                275200                 AR            Major controller of thyroid cell metabolism. Receptor for thyrotropin and thyrostimulin
  *TPO*        606765      TDH2A                                                                274500                 AR            Central role in thyroid gland function. Generation of thyroxine, T3
  *SLC5A5*     601843      TDH1                                                                 274400                 AR            Uptake of iodine by thyroid
  *DUOXA2*     612772      TDH5                                                                 274900                 AR            Thyroid hormone synthesis
  *DUOX2*      606759      TDH6                                                                 607200                 AR            Thyroid hormone synthesis
  *IYD*        612025      TDH4                                                                 274800                 AR            Hydrolysis of thyroglobulin to release iodide
  *PROP1*      601538      CPHD2                                                                262600                 AR            Involved in ontogenesis of pituitary gonadotropes, somatotropes, lactotropes and caudomedial thyrotropes
  *SLC26A4*    605646      PDS                                                                  274600                 AR            Sodium-independent transporter of iodide
  *TG*         188450      TDH3                                                                 274700                 AR            Substrate for synthesis of T4 and T3, storage of inactive forms of thyroid hormone and iodine
  *FOXI1*      601093      PDS                                                                  /                      AR            Transcription factor for *SLC26A4*
  *FOXE1*      602617      Athyroidal/ thyroidal hypothyroidism with spiky hair, cleft palate   241850                 AR            Thyroid morphogenesis
  *UBR1*       605981      JBS                                                                  243800                 AR            Degradation of substrate proteins
  *SLC16A2*    300095      AHDS                                                                 300523                 XLR           Cell import of T4, T3, T2

AHDS = Allan-Herndon-Dudley syndrome; CAHTP = choreoathetosis and congenital hypothyroidism with/without pulmonary dysfunction; CHNG = congenital nongoitrous hypothyroidism; CPHD = combined pituitary hormone deficiency; GRTH = generalized thyroid hormone resistance; GTPTS = genitopatellar syndrome; JBS = Johanson-Blizzard syndrome; PDS = Pendred syndrome; PRTH = selective pituitary thyroid hormone resistance; SBBYSS = Ohdo syndrome, SBBYS variant; TDH = thyroid dyshormono- genesis; AD = autosomal dominant; AR = autosomal recessive; XLR = X-linked recessive.

Nonautoimmune hyperthyroidism {#sec1-2}
=============================

Nonautoimmune hyperthyroidism or hereditary hyperthyroidism is a rare form of hyperthyroidism, characterized by excessive thyroid activity. Major symptoms are hyperactivity, anxiety, weight loss, exophthalmos and tachycardia ([@ref8]). Age of onset is highly variable. Clinical diagnosis is based on observation and measurement of plasma concentrations of thyroid hormone. Differential diagnosis is based on absence of exophthalmos and presence of myxedema, anti-TSH antibodies and lymphocyte infiltration of the thyroid ([@ref9]). Hyperthyroidism can be treated with drugs that inhibit thyroid activity or with ablation therapy (surgery or radioiodine) ([@ref10]).

The nonautoimmune hyperthyroidism has autosomal dominant inheritance and is caused by mutations in *TSHR* (OMIM gene: 603373; OMIM disease: 609152, 603373) ([@ref9]). Prevalence is unknown: very few families (130 patients from 22 families) and some sporadic cases, especially in Caucasian subjects, have been described ([@ref9],[@ref11]).

Pathogenic variants may be missense, nonsense, splicing or small indels. MAGI uses an NGS panel to detect nucleotide variations in coding exons and flanking introns of *TSHR*.

Conclusions {#sec1-3}
===========

We created a NGS panel to detect nucleotide variations in coding exons and flanking regions of all the genes associated with hypo- and hyperthyroidism. When one of those suspects is present we perform the analysis of all the genes present in this short article.

In order to have a high diagnostic yield, we developed a NGS test that reaches an analytical sensitivity (proportion of true positives) and an analytical specificity (proportion of true negatives) of ≥99% (coverage depth ≥10x).
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